Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ViDAS-2: Daily Vitamin D for Sickle Cell Respiratory Complications
NCT04170348Phase 2Completed
- Sponsor
- Columbia University
- Start
- Sep 2020
- Primary completion
- Jun 2024
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of vitamin d in sickle cell disease (SCD), sponsored by Columbia University. Started Sep 2020; status: completed.
02
Drugs
vitamin d
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT04170348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04170348.